Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Pediatrics and Neonatology
  • Pediatrics and Neonatology Guidelines
  • Neonatal Jaundice: IAP...

Neonatal Jaundice: IAP Guidelines

Written By : Ayesha Sadaf |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2023-04-10T09:30:08+05:30  |  Updated On 10 April 2023 11:29 AM IST
Neonatal Jaundice: IAP Guidelines
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

Neonatal jaundice is common, occurring in 60% in term and 80% in preterm infants.

Appears after 24 hours of life, decreases after 5–6 days, and undetectable after 14 days.
Maximum values seldom exceed 15 mg/dL.

The Indian Academy of Pediatrics (IAP) has released Standard Treatment Guidelines 2022 for Neonatal Jaundice. The lead author for these guidelines Neonatal Jaundice is Dr. Naveen Jain along with co-author Dr. Ravi Sachan and Dr. Praveen Vaenkatagiri. The guidelines come Under the Auspices of the IAP Action Plan 2022, and the members of the IAP Standard Treatment Guidelines Committee include Chairperson Remesh Kumar R, IAP Coordinator Vineet Saxena, National Coordinators SS Kamath, Vinod H Ratageri, Member Secretaries Krishna Mohan R, Vishnu Mohan PT and Members Santanu Deb, Surender Singh Bisht, Prashant Kariya, Narmada Ashok, Pawan Kalyan.

Following are the major recommendations of guidelines:

Severe Jaundice— Hyperbilirubinemia:

Any jaundice visible in first 24 hours of life

Yellow staining of palms and soles or deep yellow appearance (measure bilirubin values using transcutaneous bilirubinometer or laboratory testing of serum sample, when in doubt)

Bilirubin values >95 centile for gestation/weight/age in hours, evaluated on standard charts like the American Academy of Pediatrics (AAP) or National Institute for health and Care Excellence (NICE), UK) charts

Warning signs of encephalopathy such as poor feeding and lethargy

Evaluation for Risk of Hyperbilirubinemia:

Before discharge 24-72 hrs from birth All babies must be evaluated clinically for bilirubin levels while in hospital and before discharge; and confirmed objectively when in doubt, by a transcutaneous bilirubinometer or serum bilirubin plotted on hour specific nomograms. Kramer's Criteria is helpful in clinical assessment of the severity of the jaundice. The clinical assessment requires natural light (can be faulty in hospital lighting). It also depends on experience of personnel and subjectivity of assessment)

Use the hour-specific nomogram to evaluate risk before discharge from birth admission. Babies with values in high-risk zone must be re-evaluated within 24 hours

After discharge (until day 5–6 of life) from hospital

• All babies reviewed within 48 hours and babies with higher risk within 24 hours of discharge for yellow staining of palms and soles or deep yellow appearance (measure values using transcutaneous Bilirubinometer or laboratory testing of serum sample, when in doubt, use specific charts such as AAP or NICE charts to evaluate need for treatment).

• Look for lactation problems (excess weight loss and delayed transition of stool to yellow color), infrequent stool, and urine.

• Exclude early signs of encephalopathy (poor feeding and lethargy)

Close follow-up (within 24 hours of discharge) is warranted in risk groups

BOX 1: Risk groups: Need close attention.

  • Mother Rh-negative or O group

þ Gestation of baby <38 completed weeks

þ Lactation not established

þ Predischarge bilirubin in high-risk zone (transcutaneous bilirubin >13 mg/dL)

þ Cephalohematoma

  • Previous baby with jaundice

þ Glucose-6-phosphate dehydrogenase (G6PD) deficiency

History:
Gestational age and postnatal age (in hours)
Birth weight and current weight
Mode and adequacy of feeding
Urine color and number of wet nappies
Passage of meconium and color of stool
Activity and behavior during sleep/waking up
Any abnormal cry or body movements
Any bleeding/bruising
Mother's blood group and baby's blood group
Previous baby with severe neonatal jaundice
Examination:
Feature of acute bilirubin encephalopathy (hypotonia and hypertonia, lethargy, highpitched cry, poor suck, irritability, seizure, and opisthotonos posture)
Investigations:
Total serum bilirubin (TSB)
Mother and baby's blood group (collect cord blood/venous sample immediately after birth, if mother's blood group is Rh-ve)
Suspected hemolysis: Complete blood count, reticulocyte count, peripheral blood smear, and direct Coombs' test
In areas of high prevalence: Screen for glucose-6-phosphate dehydrogenase (G6PD) deficiency
For prolonged jaundice*: Total and direct bilirubin, thyroid function test, urine reducing substances, and culture. Ultrasound abdomen to exclude biliary atresia. *Prolonged jaundice: Visibly detectable jaundice beyond 2 weeks of age in a term and beyond 3 weeks of age in a preterm infant. Ask for pale stool or yellow urine, check for adequacy of weight gain. Do total and direct bilirubin test.
Management:
Hyperbilirubinemia is a potentially treatable condition. It may cause long-term neurodevelopmental impairment, if not treated timely and appropriately.
Prevention:
Early initiation and frequent breastfeeding and/or early use of mother's own milk (MOM) in neonatal intensive care unit (NICU).
Treatment:
Reducing the level of serum bilirubin by intensive phototherapy and/or exchange transfusion. Phototherapy is a noninvasive, cost effective, safe, and easy to use method; it is available at all levels of neonatal healthcare. It should be started (after sending TSB) when jaundice appears within 24 hours and/or involving palm and soles; and if TSB is in range of phototherapy as per AAP or NICE charts. Stop phototherapy, if serum bilirubin level is 2–3 mg/dL lower than the phototherapy range .
Optimizing phototherapy:
Use blue light and appropriate intensity of phototherapy (>30 µW/cm2 per nm) • Light-emitting diode (LED) and compact fluorescent lamps (CFL) most often deliver the required intensity for a long duration. A periodic check of the intensity must be done to ensure efficacy (once in 6 months).
Place phototherapy as close to baby as possible without causing hyperthermia
Expose maximum area of body
Ensure optimal breastfeeding and stool output
Indications for referral for potential exchange transfusion:
Hyperbilirubinemia (as per AAP or NICE charts) not responding to intense phototherapy
Any signs of early encephalopathy (poor feeding/lethargy) in babies with hyperbilirubinemia
Babies with hyperbilirubinemia noted within 24 hours of life, preterm babies, and previous child requiring exchange transfusion or sick babies (sepsis) with hyperbilirubinemia are at risk of developing bilirubin associated neurologic damage at values less than that indicated on standard chart. They must be referred early to centers with facilities for exchange transfusion.
Exchange transfusion is a rapid, invasive, and effective method to reduce serum bilirubin. It is a specialized procedure, performed where facilities and skills are available. If facilities are not available, refer the baby along with mother's blood sample (if mother is not accompanying).
Types of blood used for exchange transfusion:
Blood being used must be crossmatched with mother's blood.
For Rh-isoimmunization: O-negative packed cells suspended in AB plasma or O-negative whole blood or Rh-negative baby's ABO group after crossmatch.
For ABO isoimmunization: O group (Rh-compatible) packed cell suspended in AB plasma or O group whole blood (Rh-compatible with baby) after crossmatch.
In other situation, baby's blood group should be used.
Follow-up and Long-term Neurodevelopmental Outcome:
Babies who had hyperbilirubinemia must be followed up periodically using developmentscreening tools until school age. The assessments should include early language milestones. Babies who had signs of encephalopathy or required exchange transfusion must have a hearing evaluation for sensorineural hearing impairment by brainstemevoked audiometry before 6 months age.
Reference:
  • American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297-316.
  • Bhutani V, Gourley GR, Adler S, Kreamer B, Dalman C, Johnson LH. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics. 2000;106(2):E17.
  • Bhutani VK, Stark AR, Lazzeroni LC, Poland R, Gourley GR, Kazmierczak S, et al. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr. 2013;162(3):477-82.
  • Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani VK. A comparison of alternative riskassessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics. 2008;121(1):e170-9.
  • Ministry of Health and Family Welfare. Facility Based Newborn Care (FBNC) Training: Operational Guidelines. Government of India: Ministry of Health and Family Welfare; 2014.
  • Newman TB, Liljestrand P, Jeremy RJ, Ferriero DM, Wu YW, Hudes ES, et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med. 2006;354(18):1889-900.

The guidelines can be accessed on the official site of IAP: https://iapindia.org/standard-treatment-guidelines/


Indian Academy of PediatricIAP GuidelinesNeonatal jaundiceHyperbilirubinemiaencephalopathyphototherapyisoimmunization
Source : Indian Academy of Pediatric, IAP Guidelines
Ayesha Sadaf
Ayesha Sadaf

    I have done my Bachelor of pharmacy from United Institute of Pharmacy and currently pursuing pharmaceutical MBA from Jamia hamdard. I worked as an intern at the position of content creator in Medical Dialogue and am highly obliged to the company for giving me this wonderful opportunity.

    Dr. Kamal Kant Kohli
    Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    Featured image representing medico legal

    What's the Role of Expert Opinion in Medical Negligence?

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    Darbapoetin Alfa In Chemotherapy Induced Anaemia: Check out 5 takeaways from recent study

    Darbapoetin Alfa In Chemotherapy Induced Anaemia: Check out 5 takeaways from recent study

    Biosimilar Denosumab of Alkem (Denuril) shows Comparable Efficacy in Treating Postmenopausal Osteoporosis in Indian Women

    Biosimilar Denosumab of Alkem (Denuril) shows Comparable Efficacy in Treating Postmenopausal...

    View All

    Journal Club Today

    Medical Journalism: Need of the Hour - Ft: Dr Prem Aggarwal (Chairman, Medical Dialogues), Dr Nandita Mohan (Head, MDTV Division, Medical Dialogues)

    Medical Journalism: Need of the Hour - Ft: Dr Prem Aggarwal (Chairman, Medical Dialogues), Dr...

    View All

    Health News Today

    Health Bulletin 08/ May/ 2025

    Health Bulletin 08/ May/ 2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok